BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.04.2004

Guidance for Industry on Changes to an Approved NDA or ANDA; Availability

The Food and Drug Administration (FDA) is announcing the availability of a revised guidance for industry entitled "Changes to an Approved NDA or ANDA." The guidance has been revised to conform to the final rule amending the agency's regulations on changes to an approved NDA or ANDA published elsewhere in this issue of the Federal Register. The guidance is intended to assist applicants in determining how they should report changes to an approved new drug application (NDA) or an abbreviated new drug application (ANDA).

Source: Federal Register — Food and Drug AdministrationOpen original release →